Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants

BACKGROUND: Medications for opioid use disorder (MOUDs), including methadone, buprenorphine, and naltrexone, decrease mortality and morbidity for people with opioid use disorder (OUD). Buprenorphine and methadone have the strongest evidence base among MOUDs. Unlike methadone, buprenorphine may be pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Andraka-Christou, Barbara, Page, Cory, Schoebel, Victoria, Buche, Jessica, Haffajee, Rebecca L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364483/
https://www.ncbi.nlm.nih.gov/pubmed/35945636
http://dx.doi.org/10.1186/s13722-022-00321-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364483/
https://www.ncbi.nlm.nih.gov/pubmed/35945636
http://dx.doi.org/10.1186/s13722-022-00321-6

Ejemplares similares